NCT06959082 2026-03-11
Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer
VSPharmTech Co.,Ltd.
Phase 2 Recruiting
VSPharmTech Co.,Ltd.
AstraZeneca
Sapience Therapeutics
AstraZeneca
BPGbio
Hoffmann-La Roche
AstraZeneca
Coordination Pharmaceuticals, Inc.